Alembic Pharma Gets Win In Generic Gilenya Patent Case
A Virginia federal judge handed Alembic Pharmaceuticals Ltd. a win Tuesday, saying the Indian pharmaceutical company's generic alternative to Novartis AG and Mitsubishi Tanabe Pharma Corp.'s multiple sclerosis drug Gilenya does...To view the full article, register now.
Already a subscriber? Click here to view full article